7th Circ. Declines To Revive Humira 'Patent Thicket' Claims

By Hailey Konnath and Bryan Koenig · August 1, 2022, 8:08 PM EDT

A Seventh Circuit panel on Monday refused to revive landmark private antitrust claims from Humira buyers accusing pharmaceutical giant AbbVie of using a "patent thicket" to illegally shield the blockbuster immunosuppressant...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

Mayor and City Council of Baltimore, et al v. AbbVie Inc., et al

Case Number

Court

Appellate - 7th Circuit

Nature of Suit

3410 Antitrust

Date Filed

July 30, 2020

Recent Articles By Hailey

November 14, 2024
Ex-Ga. Rep. Doug Collins To Head Trump's Veterans Affairs
November 12, 2024
Trump Taps Elon Musk To Head New 'Gov't Efficiency' Dept.
November 04, 2024
Kroger, State AGs Finalize Sprawling $1.37B Opioid Deal
October 24, 2024
McDonald's Customers File First Suits Over E. Coli Outbreak
October 23, 2024
TriZetto Gets New Damages Trial After Ax Of $200M Awards
October 21, 2024
Google, Meta Want Out Of GoodRx Health Data Sharing Suit
October 18, 2024
HHS Slams Hackensack Meridian's Chevron-Inspired Suit
October 08, 2024
Cedars-Sinai OB-GYN Accused Of Abusing, Harassing Patients
October 08, 2024
Apple Loses Bid For Jury Trial In Masimo Trade Secrets Fight
October 07, 2024
Mednax Gets Final OK For $6M Data Breach Settlement